C69.80

The ICD-10-CM code for malignant neoplasm of ovrlp sites of unsp eye and adnexa is C69.80. The full clinical description is "Malignant neoplasm of overlapping sites of unspecified eye and adnexa". C69.80 is a billable/specific code that can be used on insurance claims and medical billing.

ICD-10-CM code C69.80 represents “Malignant neoplasm of overlapping sites of unspecified eye and adnexa”. It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.

Yes, C69.80 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

C69.80 is in Chapter 2: Neoplasms (codes C00-D49).

C69.80 has Excludes1 notes indicating codes that cannot be used together with it, including: malignant neoplasm of connective tissue of eyelid (C49.0); malignant neoplasm of eyelid (skin) (C43.1-, C44.1-); malignant neoplasm of optic nerve (C72.3-).

C69.80 maps to 3 SNOMED CT concepts: 866073009, 109948008, 735917000. SNOMED CT is a clinical terminology used in electronic health records.

C69.80 is linked to 1 UMLS Concept Unique Identifier: C2845922. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like malignant neoplasm of ovrlp sites of unsp eye and adnexa affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

There is no direct ICD-11 mapping available for C69.80 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.